Insights

Why these ASX shares just raced to 52-week highs or better

Costa Group Holdings Ltd (ASX:CGC) and these ASX shares have just raced to 52-week highs or better this week. Here’s why…
The post Why these ASX shares just raced to 52-week highs or better appeared first on The Motley Fool Australia. –

jump in asx share price represented by man jumping in the air in celebration

Although the Australian share market has been out of form over the last few trading days, that hasn’t stopped a number of shares from charging higher.

Three ASX shares that have climbed so much they just hit 52-week highs or better are listed below. Here’s why they are flying high right now:

Costa Group Holdings Ltd (ASX: CGC)

The Costa share price jumped to a 52-week high of $4.55 yesterday. Investors were buying the horticulture company’s shares after the release of its full year results. Thanks to strong demand and favourable pricing, Costa reported an 11.2% increase in revenue to $1,164 million and an impressive 108.4% jump in net profit to $59.4 million. This was well ahead of expectations. For example, Morgans was forecasting a profit of $52.2 million for the 12 months, whereas the market consensus was for a profit of $48.1 million.

Lovisa Holdings Ltd (ASX: LOV)

The Lovisa share price stormed to a record high of $15.43 on Monday. Investors have been fighting to get hold of the fashion jewellery retailer’s shares since the release of its half year results last week. Although Lovisa reported a sizeable decline in sales and profits, it noted a significant improvement in its performance. It also revealed that it has started the second half strongly, with like for like sales growing 12% during the first seven weeks of the half. Looking ahead, management appears very positive on its global expansion. As are analysts at Morgans. Partly for this reason, the broker reaffirmed its add rating and lifted its price target significantly to $17.95.

Pro Medicus Limited (ASX: PME)

The Pro Medicus share price rose to a new record high of $48.24 yesterday. A series of major contract wins has helped drive this health imaging company’s shares higher in recent months. In addition to this, last week analysts at Goldman Sachs upgraded Pro Medicus’ shares to a buy rating with a $53.80 price target. Goldman has been impressed with the way the company continues to win large contracts in a difficult operating environment. It believes this leaves it well-positioned to grow its earnings at a rapid rate over the coming years.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended COSTA GRP FPO. The Motley Fool Australia has recommended Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why these ASX shares just raced to 52-week highs or better appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!